GlassScriptPhysician profile
Nicole B Quilty
NPI 1285048090
$492.06
in general payments reported to CMS, 2019-2025
13 companies · $49.45 in 2025
The $49.45 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $68.30 · 2023: $132 · 2024: $140 · 2025: $49.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $126.91 | 2021-2025 | |
| Vertex Pharmaceuticals Incorporated | $86.41 | 2024 | |
| Collegium Pharmaceutical, INC. | $86.32 | 2021-2023 | Xtampza |
| Nevro Corp. | $31.70 | 2024 | Senza |
| Abbott Laboratories | $26.43 | 2021-2024 | Eterna |
| Lundbeck LLC | $20.53 | 2023 | Vyepti |
| Spr Therapeutics, INC | $20.26 | 2023-2024 | Sprint Pns System |
| Medtronic, INC. | $19.30 | 2022 | |
| Amneal Pharmaceuticals LLC | $17.58 | 2023 | Lyvispah |
| Ibsa Pharma INC. | $15.43 | 2025 | Licart, Flector, Tirosint |
| International Rehabilitative Sciences, INC | $14.53 | 2023 | Rs 4i Plus Sequential Stimulator |
| Pfizer INC. | $14.39 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Quilty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.